Home » FDA Approves Baxter’s Advate for Routine Prophylaxis in Adults, Children With Hemophilia A
FDA Approves Baxter’s Advate for Routine Prophylaxis in Adults, Children With Hemophilia A
Baxter International announced that the FDA has approved Advate [Antihemophilic Factor (Recombinant) Plasma/Albumin Free Method] for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A.
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May